As Katie Powers prepared to have “a simple procedure” to remove a benign tumor on her brain, she looked forward to returning ...

Biohaven (BHVN) downgraded after FDA setback for VYGLXIA. Learn key risks, pipeline shifts, and what investors should watch next. Click here to read more.

When there are so few taxis in your regional city that you can actually use, it can be detrimental to your independence when ...

Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...

Lottie was a healthy, happy two-year-old when she caught a common cold. Her parents Matt Garrett and Jess Tillbrook weren't too worried, until they spotted a tremor in their daughter's hand. "It was ...

ClearPoint Neuro, Inc. ( CLPT) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST [Audio Gap] comments made on this call may include statements that are forward-looking within the meaning of ...

BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced third-quarter 2025 financial results and a clinical ...

Hypocalcemia—also known as low blood calcium—is one of the most frightening medical emergencies parrot owners face. African ...

While having one of the 118 health conditions doesn't automatically mean being unable to drive the DVLA still needs to be ...

A recent study of clinical and genetic characteristics in patients with hereditary spastic paraplegia highlights the difficulties of making clinicogenetic correlations in a heterogeneous group of ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU. Skyclarys ...

A baby was diagnosed with a brain tumour after he struggled to sit up and use his left hand - symptoms which were initially put down to developmental delays. Jordy Arthur was 10 months old in March, ...